Effects of Intensive Antiplatelet Therapy for Patients With Clopidogrel Resistance After Coronary Stent Implantation
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
Clopidogrel resistance (CR) or low-responsiveness is associated with increased risk of
ischemic events and can be detected by laboratory tests. This multicenter, randomized study
is aimed to explore the efficacy and safety of intensive antiplatelet therapy (i.e. double
clopidogrel maintenance dose and/or additional cilostazol)for patients with CR after coronary
stenting.